Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 45/100

Failure Rate

0.0%

0 terminated/withdrawn out of 28 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

7%

2 trials in Phase 3/4

Results Transparency

0%

0 of 11 completed trials have results

Key Signals

14 recruiting

Enrollment Performance

Analytics

N/A
9(56.3%)
Phase 2
4(25.0%)
Phase 4
2(12.5%)
Phase 1
1(6.3%)
16Total
N/A(9)
Phase 2(4)
Phase 4(2)
Phase 1(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (28)

Showing 20 of 28 trials
NCT04347200Recruiting

REGistry of Long-term AnTithrombotic TherApy-1

Role: lead

NCT04347187Recruiting

REGistry of Long-term AnTithrombotic TherApy-2

Role: lead

NCT05795400Not ApplicableCompleted

Administration of the SGLT-2 Inhibitor Dapagliflozin in the Patients With Amyloid Cardiomyopathy

Role: lead

NCT06655480Phase 2Recruiting

Triple Combination Therapy (ARNI, SGLT2i, MRA) in Advanced HFpEF

Role: lead

NCT06248658Completed

Assessment of the Impact of Clinical Decision Support Systems Included in Electronic Health Records

Role: lead

NCT06844032Recruiting

Predictors of Poor Prognosis in HFpEF

Role: lead

NCT06683001Recruiting

National Heart Failure Registry

Role: lead

NCT04160533Recruiting

Registry of Arterial Hypertension

Role: lead

NCT06683040Phase 2Active Not Recruiting

Evaluation of the Efficacy and Safety of Oxacom® in Patients With Pulmonary Arterial Hypertension

Role: lead

NCT06540352Phase 2Active Not Recruiting

A Study to Select the Dose and Evaluate the Effectiveness and Safety of the Drug Refralon®, Tablets, 1 mg for Long-term Use to Prevent Recurrence of Atrial Fibrillation/Flutter After Terminating Its Persistent Form

Role: lead

NCT07452991Not ApplicableRecruiting

ULTRAsound-assisted Catheter-guided Thrombolysis for Intermediate-high Risk Patients With PE

Role: lead

NCT07245927Recruiting

Post-registration Trial of the Non-immunogenic Staphylokinase in Massive Pulmonary Embolism

Role: collaborator

NCT07149714Not ApplicableRecruiting

Temporary MCS With the iVAC 2L Transaortic Device in High-risk PCI

Role: lead

NCT03928158Phase 2Completed

LCZ696 in Advanced LV Hypertrophy and HFpEF

Role: lead

NCT05445297Phase 4Completed

Refralon Versus Amiodarone for Cardioversion of Paroxysmal Fibrillation and Atrial Flutter

Role: lead

NCT05456204Not ApplicableCompleted

Refralon in Patients With Recurrence Paroxysmal and Persistent Forms of Atrial Fibrillation Who Underwent Catheter Ablation

Role: lead

NCT06156670Recruiting

Russian Registry of Endovascular Closure of PFO

Role: lead

NCT06633159Recruiting

MitraClip in Patients With Heart Failure

Role: collaborator

NCT06376630Not ApplicableRecruiting

Study of Microvascular Dysfunction, CFR and Cardioprotective Effect of Early Administration of Esmolol in MI

Role: lead

NCT06288633Not ApplicableRecruiting

Cardioneuroablation for Bradyarrhythmia

Role: collaborator